methotrexate has been researched along with FMR1-Related Primary Ovarian Insufficiency in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (15.38) | 18.2507 |
| 2000's | 4 (30.77) | 29.6817 |
| 2010's | 7 (53.85) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benian, A; Guralp, O; Okyar, A; Sahmay, S; Uzun, DD | 1 |
| Lustberg, MB; Oostra, DR; Pan, X; Reinbolt, RE; Shapiro, CL; Wesolowski, R | 1 |
| Hoek, A; Sanders, JS; Stegeman, CA; Tuin, J; van Beek, AP | 1 |
| Fornander, T; Johansson, H; Nystedt, M; Sverrisdottir, A | 1 |
| RodrÃguez-Lescure, A | 1 |
| Bighin, C; Boni, L; Cresti, N; Del Mastro, L; Gamucci, T; Garrone, O; Giordano, M; Giraudi, S; Gori, S; Levaggi, A; Magnolfi, E; Michelotti, A; Olmeo, N; Pronzato, P; Scotto, T; Vecchio, C; Venturini, M | 1 |
| Gordon, AM; Hurwitz, S; LeBoff, MS; Shapiro, CL | 1 |
| Allen, NB; Chow, SC; Clowse, ME; Copland, SC; Davis, JC; Hoffman, GS; Hsieh, TC; McCune, WJ; Merkel, PA; Specks, U; Spiera, RF; St Clair, EW; Stone, JH; Ytterberg, SR | 1 |
| Blomqvist, C; Elomaa, I; Saarto, T; Taskinen, MR; Vehmanen, L | 1 |
| Blomqvist, C; Elomaa, I; Risteli, J; Risteli, L; Saarto, T; Vehmanen, L | 1 |
| Espirito, JL; Games, DM; McCune, JS | 1 |
| Blau, R; Gazder, P; Lower, EE; Tummala, R | 1 |
| Bakri, YN; Nassar, M; Pedersen, P | 1 |
5 trial(s) available for methotrexate and FMR1-Related Primary Ovarian Insufficiency
| Article | Year |
|---|---|
Adjuvant goserelin and ovarian preservation in chemotherapy treated patients with early breast cancer: results from a randomized trial.
Topics: Adult; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Female; Fluorouracil; Goserelin; Humans; Methotrexate; Middle Aged; Ovarian Function Tests; Ovary; Premenopause; Primary Ovarian Insufficiency; Tamoxifen | 2009 |
Effect of the gonadotropin-releasing hormone analogue triptorelin on the occurrence of chemotherapy-induced early menopause in premenopausal women with breast cancer: a randomized trial.
Topics: Adult; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cisplatin; Female; Fluorouracil; Goserelin; Humans; Infertility, Female; Injections, Intramuscular; Luteolytic Agents; Menopause; Methotrexate; Middle Aged; Neoadjuvant Therapy; Premenopause; Primary Ovarian Insufficiency; Tamoxifen; Triptorelin Pamoate | 2011 |
Ovarian reserve diminished by oral cyclophosphamide therapy for granulomatosis with polyangiitis (Wegener's).
Topics: Administration, Oral; Adolescent; Adult; Anti-Mullerian Hormone; Biomarkers; Cyclophosphamide; Double-Blind Method; Etanercept; Female; Follicle Stimulating Hormone, Human; Granulomatosis with Polyangiitis; Humans; Immunoglobulin G; Immunosuppressive Agents; Methotrexate; Middle Aged; Ovary; Primary Ovarian Insufficiency; Receptors, Tumor Necrosis Factor; Time Factors; Treatment Outcome; United States; Young Adult | 2011 |
Tamoxifen treatment reverses the adverse effects of chemotherapy-induced ovarian failure on serum lipids.
Topics: Adult; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Clodronic Acid; Cyclophosphamide; Female; Fluorouracil; Humans; Lipoproteins; Methotrexate; Middle Aged; Premenopause; Primary Ovarian Insufficiency; Receptors, Estrogen; Tamoxifen | 2004 |
Short-term intermittent intravenous clodronate in the prevention of bone loss related to chemotherapy-induced ovarian failure.
Topics: Adult; Antimetabolites; Antineoplastic Combined Chemotherapy Protocols; Bone Resorption; Breast Neoplasms; Chemotherapy, Adjuvant; Clodronic Acid; Cyclophosphamide; Drug Administration Schedule; Epirubicin; Female; Fluorouracil; Humans; Infusions, Intravenous; Methotrexate; Middle Aged; Premenopause; Primary Ovarian Insufficiency | 2004 |
8 other study(ies) available for methotrexate and FMR1-Related Primary Ovarian Insufficiency
| Article | Year |
|---|---|
The effect of repeated administration of methotrexate (MTX) on rat ovary: measurement of serum antimullerian hormone (AMH) levels.
Topics: Animals; Anti-Mullerian Hormone; Antimetabolites, Antineoplastic; Antirheumatic Agents; Biomarkers; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Female; Immunosuppressive Agents; Methotrexate; Nucleic Acid Synthesis Inhibitors; Ovary; Primary Ovarian Insufficiency; Rats; Rats, Wistar; Reproducibility of Results | 2013 |
Association of osteoprotegerin and bone loss after adjuvant chemotherapy in early-stage breast cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Humans; Methotrexate; Middle Aged; Osteoporosis; Osteoprotegerin; Primary Ovarian Insufficiency | 2015 |
Brief Report: Menopause and Primary Ovarian Insufficiency in Women Treated for Antineutrophil Cytoplasmic Antibody-Associated Vasculitides.
Topics: Adult; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Azathioprine; Case-Control Studies; Cohort Studies; Cyclophosphamide; Dose-Response Relationship, Drug; Female; Humans; Immunosuppressive Agents; Incidence; Maintenance Chemotherapy; Menopause; Methotrexate; Middle Aged; Mycophenolic Acid; Prednisolone; Primary Ovarian Insufficiency; Remission Induction; Retrospective Studies; Risk Factors; Rituximab; Young Adult | 2016 |
Adjuvant chemotherapy in young women with breast cancer.
Topics: Adult; Age Factors; Amenorrhea; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Female; Fluorouracil; Genes, erbB-2; Humans; Methotrexate; Primary Ovarian Insufficiency; Risk Factors; SEER Program; Taxoids | 2010 |
Premature ovarian failure and body composition changes with adjuvant chemotherapy for breast cancer.
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Body Composition; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Follow-Up Studies; Humans; Methotrexate; Middle Aged; Premenopause; Primary Ovarian Insufficiency; Prospective Studies; Tamoxifen; Weight Gain | 2011 |
Assessment of ovarian failure and osteoporosis in premenopausal breast cancer survivors.
Topics: Absorptiometry, Photon; Administration, Oral; Adult; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Bone Density; Breast Neoplasms; Calcium; Contraceptives, Oral; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Drug Utilization Review; Estradiol; Female; Fluorouracil; Follicle Stimulating Hormone; Follow-Up Studies; Goserelin; Humans; Medical Records; Menstruation Disturbances; Methotrexate; Osteoporosis, Postmenopausal; Premenopause; Primary Ovarian Insufficiency; Process Assessment, Health Care; Retrospective Studies; Survivors; Tamoxifen; Time Factors | 2005 |
The risk of premature menopause induced by chemotherapy for early breast cancer.
Topics: Adult; Amenorrhea; Antibiotics, Antineoplastic; Antineoplastic Agents; Breast Neoplasms; Estradiol; Female; Follicle Stimulating Hormone; Follow-Up Studies; Humans; Menopause, Premature; Methotrexate; Primary Ovarian Insufficiency; Retrospective Studies; Risk Factors; Time Factors | 1999 |
Normal pregnancy after curative multiagent chemotherapy for choriocarcinoma with brain metastases.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Choriocarcinoma; Cisplatin; Dactinomycin; Etoposide; Female; Humans; Lung Neoplasms; Methotrexate; Pregnancy; Pregnancy Complications, Neoplastic; Primary Ovarian Insufficiency; Uterine Neoplasms | 1991 |